Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.
See the original post:
Latisse Faces Patent Challenge
Comments
Leave a Reply
Hello. I am Jennifer.
Chat with me if you have any questions.
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.
See the original post:
Latisse Faces Patent Challenge
Tags: a-generic-version-, allergan, eyelash, eyelash-drug, fda, for-the, generic-version-, health, latisse, patent-protection, wsj
Leave a Reply
© 2012 Latisse - Terms | Privacy Policy
NOTICE TO CONSUMERS: Medical doctors are licensed and regulated by the Medical Board of California (800) 633-2322 (www.mbc.ca.gov)
Simon Ourian, M.D.
Our chief Cosmetic Dermatologist is Simon Ourian, M.D. Our Cosmetic dermatologist offers advanced dermatology laser treatments. We service locations throughout Southern California including Los Angeles, Palmdale, Valencia, Ridgecrest and Riverside / Corona. Surrounding cities include Beverly Hills, Brentwood, Encino, Thousand Oaks, Calabasas, Glendale, Hollywood, Long Beach, Oxnard, Pacific Palisades, Reseda, Santa Monica, Sherman Oaks, and Woodland Hills.
Thank you for visiting www.latisseonline.com!
Some of the articles presented on this Web site are accessed through RSS feeds from third-party sources that are not necessarily part of www.latisseonline.com. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by www.latisseonline.com.
